UBS Maintains a 'Sell' on athenahealth (ATHN); Decent Quarter, But Valuation Too High
Tweet Send to a Friend
UBS maintains a 'Sell' on athenahealth (NASDAQ: ATHN) price target of $58.00 (from $34.00).
Analyst, Stephen Shankman, said, "In ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Stephen Shankman, said, "In ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
